Clinical Impact and Cost-Effectiveness of Updated 2023/24 COVID-19 mRNA Vaccination in High-Risk Populations in the United States
美国高危人群中更新的2023/24年COVID-19 mRNA疫苗的临床影响和成本效益
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-025-01128-z
Joshi, Keya; Dronova, Mariia; Paterak, Ewelina; Nguyen, Van H; Kopel, Hagit; Mansi, James; Van de Velde, Nicolas; Beck, Ekkehard